Drug Trial Radar · NCT04233866
Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread
Last checked: Nov 19, 2026Latest source record: Jul 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
176
Actual
Start
Aug 26, 2020
Primary completion
Mar 2, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- ECOG-ACRIN Cancer Research GroupResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Jan 18, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase II trial compares two treatment combinations: gemcitabine hydrochloride and nab-paclitaxel, or fluorouracil, leucovorin calcium, and liposomal irinotecan in older patients with pancreatic cancer that has spread to other places in the body (metastatic). Drugs used in chemotherapy, such as gemcitabine hydrochloride, nab-paclitaxel, fluorouracil, leucovorin calcium, and liposomal irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This study may help doctors find out which treatment combination is better at prolonging life in older patients with metastatic pancreatic cancer.
Conditions
- Metastatic Pancreatic Adenocarcinoma
- Stage IV Pancreatic Cancer AJCC v8
Interventions
FluorouracilDrug
Given IV
GemcitabineDrug
Given IV
Gemcitabine HydrochlorideDrug
Given IV
LeucovorinDrug
Given IV
Leucovorin CalciumDrug
Given IV
Liposomal IrinotecanDrug
Given IV
Nab-paclitaxelDrug
Given IV
Quality-of-Life AssessmentOther
Ancillary studies
Questionnaire AdministrationOther
Ancillary studies
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall survival (OS)Time frame: Up to 2 years post treatment
Locations
760 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama
Thomas Hospital
Fairhope, Alabama
Mobile Infirmary Medical Center
Mobile, Alabama
Anchorage Associates in Radiation Medicine
Anchorage, Alaska
Anchorage Radiation Therapy Center
Anchorage, Alaska
Alaska Breast Care and Surgery LLC
Anchorage, Alaska
Alaska Oncology and Hematology LLC
Anchorage, Alaska
Alaska Women's Cancer Care
Anchorage, Alaska
Anchorage Oncology Centre
Anchorage, Alaska
Katmai Oncology Group
Anchorage, Alaska
Providence Alaska Medical Center
Anchorage, Alaska
Kingman Regional Medical Center
Kingman, Arizona
Cancer Center at Saint Joseph's
Phoenix, Arizona
Mercy Hospital Fort Smith
Fort Smith, Arkansas
CHI Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas
Mission Hope Medical Oncology - Arroyo Grande
Arroyo Grande, California
PCR Oncology
Arroyo Grande, California
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Burbank, California
Mercy Cancer Center �� Carmichael
Carmichael, California
Mercy San Juan Medical Center
Carmichael, California
Community Cancer Institute
Clovis, California
University Oncology Associates
Clovis, California
City of Hope Comprehensive Cancer Center
Duarte, California
Mercy Cancer Center - Elk Grove
Elk Grove, California
City of Hope at Irvine Lennar
Irvine, California
UC Irvine Health/Chao Family Comprehensive Cancer Center
Orange, California
Stanford Cancer Institute Palo Alto
Palo Alto, California
Mercy Cancer Center - Rocklin
Rocklin, California
Mercy Cancer Center - Sacramento
Sacramento, California
Salinas Valley Memorial
Salinas, California
Pacific Central Coast Health Center-San Luis Obispo
San Luis Obispo, California
Mission Hope Medical Oncology - Santa Maria
Santa Maria, California
City of Hope South Pasadena
South Pasadena, California
City of Hope Upland
Upland, California
Woodland Memorial Hospital
Woodland, California
Penrose-Saint Francis Healthcare
Colorado Springs, Colorado
Rocky Mountain Cancer Centers-Penrose
Colorado Springs, Colorado
UCHealth Memorial Hospital Central
Colorado Springs, Colorado
Memorial Hospital North
Colorado Springs, Colorado
Showing 40 of 760 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.